Company Filing History:
Years Active: 2018
Title: Innovations of Md Mamunul Haque in Neurodegenerative Disease Treatment
Introduction
Md Mamunul Haque is an accomplished inventor based in Seoul, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of tau-related diseases. His innovative work focuses on developing compounds that can prevent or treat neurodegenerative diseases, such as Alzheimer's disease.
Latest Patents
One of his notable patents is the levosimendan compound for preventing or treating tau-related diseases. This patent discloses a levosimendan compound, an optically active isomer thereof, or a pharmaceutically acceptable salt thereof. The compound is utilized for the prevention and/or treatment of diseases caused by tau aggregation or phosphorylation. This includes neurodegenerative diseases, which are a growing concern in modern medicine. Additionally, the invention provides a health functional food for preventing or treating tau aggregation-related diseases, containing the levosimendan compound or its pharmaceutically acceptable salt, stereoisomer, or solvate.
Career Highlights
Md Mamunul Haque is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His work has led to advancements in understanding and treating complex diseases that affect millions of people worldwide. His dedication to innovation in the medical field is evident through his patent and ongoing research efforts.
Collaborations
He collaborates with esteemed colleagues, including Yun Kyung Kim and Sung Su Lim, who contribute to his research initiatives. Their combined expertise enhances the potential impact of their work in the field of neurodegenerative disease treatment.
Conclusion
Md Mamunul Haque's innovative contributions to the treatment of tau-related diseases highlight the importance of research in combating neurodegenerative conditions. His work not only advances scientific knowledge but also offers hope for effective treatments in the future.